{"result": {"id": "ed867613-a196-4715-a696-c1a1aecf9b3a", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>CHINESE CHRONIC KIDNEY DISEASE NUTRITION TREATMENT CLINICAL PRACTICE GUIDELINE (2021 EDITION)<|>EVENT<|>A clinical practice guideline for nutrition treatment in chronic kidney disease published in 2021\")  \n##\n(\"entity\"<|>JACC CARDIOVASC INTERV<|>ORGANIZATION<|>Journal publishing research on cardiovascular interventions\")  \n##\n(\"entity\"<|>LANCET RESPIR MED<|>ORGANIZATION<|>Medical journal publishing respiratory research\")  \n##\n(\"entity\"<|>J AM HEART ASSOC<|>ORGANIZATION<|>Journal of the American Heart Association publishing cardiovascular research\")  \n##\n(\"entity\"<|>HYPERTENSION<|>ORGANIZATION<|>Journal publishing hypertension research\")  \n##\n(\"entity\"<|>DIS MARKERS<|>ORGANIZATION<|>Journal publishing disease marker research\")  \n##\n(\"entity\"<|>OBES RES CLIN PRACT<|>ORGANIZATION<|>Journal publishing obesity research\")  \n##\n(\"entity\"<|>OXID MED CELL LONGEV<|>ORGANIZATION<|>Journal publishing oxidative medicine research\")  \n##\n(\"entity\"<|>NAT SCI SLEEP<|>ORGANIZATION<|>Journal publishing sleep science research\")  \n##\n(\"entity\"<|>J INFLAMM RES<|>ORGANIZATION<|>Journal publishing inflammation research\")  \n##\n(\"entity\"<|>CURR CARDIOL REP<|>ORGANIZATION<|>Journal publishing current cardiology reports\")  \n##\n(\"entity\"<|>FRONT CARDIOVASC MED<|>ORGANIZATION<|>Journal publishing cardiovascular medicine research\")  \n##\n(\"entity\"<|>EUR J ENDOCRINOL<|>ORGANIZATION<|>European journal of endocrinology\")  \n##\n(\"entity\"<|>FRONT ENDOCRINOL (LAUSANNE)<|>ORGANIZATION<|>Journal publishing endocrinology research\")  \n##\n(\"entity\"<|>RISK MANAG HEALTHC POLICY<|>ORGANIZATION<|>Journal publishing healthcare risk management research\")  \n##\n(\"relationship\"<|>CHINESE PHYSICIANS ASSOCIATION NEPHROLOGY DIVISION<|>CHINESE CHRONIC KIDNEY DISEASE NUTRITION TREATMENT CLINICAL PRACTICE GUIDELINE (2021 EDITION)<|>Developed the clinical practice guideline<|>9\")  \n##\n(\"relationship\"<|>CHINESE SOCIETY OF INTEGRATIVE MEDICINE NEPHROLOGY COMMITTEE<|>CHINESE CHRONIC KIDNEY DISEASE NUTRITION TREATMENT CLINICAL PRACTICE GUIDELINE (2021 EDITION)<|>Collaborated on developing the clinical practice guideline<|>8\")  \n##\n(\"relationship\"<|>PRINCE M<|>JACC CARDIOVASC INTERV<|>Published research in this journal<|>6\")  \n##\n(\"relationship\"<|>BENJAFIELD AV<|>LANCET RESPIR MED<|>Published research in this journal<|>6\")  \n##\n(\"relationship\"<|>TIETJENS JR<|>J AM HEART ASSOC<|>Published research in this journal<|>6\")  \n##\n(\"relationship\"<|>MARTÍNEZ-GARCÍA MA<|>HYPERTENSION<|>Published research in this journal<|>6\")  \n##\n(\"relationship\"<|>LI N<|>DIS MARKERS<|>Published research in this journal<|>6\")  \n##\n(\"relationship\"<|>YAO L<|>OBES RES CLIN PRACT<|>Published research in this journal<|>6\")  \n##\n(\"relationship\"<|>CAI X<|>OXID MED CELL LONGEV<|>Published research in this journal<|>6\")  \n##\n(\"relationship\"<|>HU J<|>NAT SCI SLEEP<|>Published research in this journal<|>6\")  \n##\n(\"relationship\"<|>CAI X<|>J INFLAMM RES<|>Published research in this journal<|>6\")  \n##\n(\"relationship\"<|>SALMAN LA<|>CURR CARDIOL REP<|>Published research in this journal<|>6\")  \n##\n(\"relationship\"<|>MANSUKHANI MP<|>FRONT CARDIOVASC MED<|>Published research in this journal<|>6\")  \n##\n(\"relationship\"<|>GAN L<|>EUR J ENDOCRINOL<|>Published research in this journal<|>6\")  \n##\n(\"relationship\"<|>GAN L<|>FRONT ENDOCRINOL (LAUSANNE)<|>Published research in this journal<|>6\")  \n##\n(\"relationship\"<|>WANG M<|>RISK MANAG HEALTHC POLICY<|>Published research in this journal<|>6\")  \n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751559137, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 1121, "prompt_tokens": 4965, "total_tokens": 6086, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 4864}, "prompt_cache_hit_tokens": 4864, "prompt_cache_miss_tokens": 101}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: .\n[680]  高血压肾病诊治中国专家共识组成员.  高血压肾病诊断和治疗  中国专家共识(2022) [J]. 中华高血压杂志 , 2022, 30(4) : 307- 317.\n[681]  中国医师协会肾脏内科医师分会 , 中国中西医结合学会肾脏疾 病专业委员会营养治疗指南专家协作组.  中国慢性肾脏病营养 治疗临床实践指南(2021版) [J]. 中华医学杂志 ,2021, 101(8) : 539-559.\n[682]  PrinceM, TafurJD, WhiteCJ.  Whenandhow shouldwerevas- cularizepatientswith atheroscleroticrenalartery stenosis?  [J].   JACCCardiovascInterv,2019,12(6) :505-517.\n[683]  Benjafield AV, Ayas NT, Eastwood PR, et al.  Estimation of theglobalprevalence and burden ofobstructive sleep apnoea: a literature-basedanalysis[J]. LancetRespirMed,2019,7(8) :687- 698.\n[684]  Tietjens JR, Claman D, Kezirian EJ, et al.  Obstructive sleep apnea in cardiovascular disease: a review of the literature and proposed multidisciplinary clinical management strategy[J]. J Am HeartAssoc,2019,8(1) :e010440.\n[685]  Martínez-GarcíaMA, Navarro-Soriano C, TorresG, etal. Be- yond resistanthypertension[J]. Hypertension,2018, 72(3) : 618- 624.\n[686]  LiN, CaiX, Zhu Q, etal. Association between plasma homo- cysteine concentrationsandthefirstischemicstrokeinhyperten- sivepatientswithobstructivesleep apnea: a7-yearretrospective cohortstudyfrom China[J]. DisMarkers,2021,2021:9953858.\n[687]  Yao L, HeizhatiM, LinM, etal. Elevatedbodymassindexin- creasestherisk ofcardiovasculareventsin hypertensivepatients\n\n\naccompanied with obstructive sleep apnea: a cohort study[J]. ObesResClin Pract,2022,16(6) :491-499.\n[688]  CaiX, HuJ, WenW , etal. Associationsofthecardiometabolic indexwith therisk ofcardiovasculardiseaseinpatientswithhy- pertension and obstructive sleep apnea: resultsofa longitudinal cohortstudy[J]. OxidMed CellLongev,2022,2022:4914791.\n[689]  HuJ, CaiX, LiN, etal. Association between triglycerideglu- coseindex-waist circumference and risk of first myocardial in- farction in Chinese hypertensive patients with obstructive sleep apnoea: an observationalcohort study[J]. NatSciSleep, 2022,  14:969-980.\n[690]  CaiX, LiN, Hu J, etal. Nonlinearrelationship between Chinese visceraladiposity index and new-onset myocardial infarction in patientswithhypertensionandobstructivesleepapnoea: insights from a cohortstudy[J]. J Inflamm Res,2022,15:687-700.\n[691]  Salman LA, Shulman R, Cohen JB.   Obstructive sleep apnea,  hypertension,  and  cardiovascular risk:  epidemiology,  patho- physiology, and management[J]. Curr Cardiol Rep, 2020, 22\n(2) :6.\n[692]  MansukhaniMP, KollaBP, SomersVK.  Hypertensionandcog- nitivedecline: implications ofobstructive sleep apnea[J]. Front CardiovascMed,2019,6:96.\n[693]  Gan L, LiN, HeizatiM, et al.  Diurnal cortisolfeatures with cardiovasculardisease in hypertensive patients: a cohort study [J]. EurJ Endocrinol,2022,187(5) :629-636.\n[694]  Gan L, LiN, HeizhatiM, etal.  Higherplasma aldosterone is associatedwithincreased risk ofcardiovascular events in hyper- tensivepatientswith suspected OSA: UROSAH data[J]. Front Endocrinol(Lausanne) ,2022,13:1017177.\n[695]  WangM, Wang M, Zhu Q, etal.  Developmentand validation ofa coronaryheartdiseaserisk prediction modelin snorerswith hypertension: a retrospective observed study[J]. Risk Manag HealthcPolicy,2022,15:1999-2009.\n[696]  WangMH, HeizhatiM, LiNF, etal. Developmentandvalida- tion ofaprognosticmodelto predicthigh-risk\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>HYPERTENSIVE NEPHROPATHY DIAGNOSIS AND TREATMENT CHINESE EXPERT CONSENSUS (2022)<|>EVENT<|>A consensus document on the diagnosis and treatment of hypertensive nephropathy by Chinese experts in 2022\")  \n##\n(\"entity\"<|>CHINESE MEDICAL JOURNAL<|>ORGANIZATION<|>A medical journal publishing the Chinese Chronic Kidney Disease Nutrition Treatment Clinical Practice Guideline (2021 Edition)\")  \n##\n(\"entity\"<|>CHINESE PHYSICIANS ASSOCIATION NEPHROLOGY DIVISION<|>ORGANIZATION<|>An association involved in creating guidelines for chronic kidney disease nutrition treatment\")  \n##\n(\"entity\"<|>CHINESE SOCIETY OF INTEGRATIVE MEDICINE NEPHROLOGY COMMITTEE<|>ORGANIZATION<|>A committee collaborating on clinical nutrition guidelines for chronic kidney disease\")  \n##\n(\"entity\"<|>PRINCE M<|>PERSON<|>Author of a study on revascularization in atherosclerotic renal artery stenosis\")  \n##\n(\"entity\"<|>TAFUR JD<|>PERSON<|>Co-author of a study on revascularization in atherosclerotic renal artery stenosis\")  \n##\n(\"entity\"<|>WHITE CJ<|>PERSON<|>Co-author of a study on revascularization in atherosclerotic renal artery stenosis\")  \n##\n(\"entity\"<|>BENJAFIELD AV<|>PERSON<|>Author of a study on the global prevalence of obstructive sleep apnea\")  \n##\n(\"entity\"<|>AYAS NT<|>PERSON<|>Co-author of a study on the global prevalence of obstructive sleep apnea\")  \n##\n(\"entity\"<|>EASTWOOD PR<|>PERSON<|>Co-author of a study on the global prevalence of obstructive sleep apnea\")  \n##\n(\"entity\"<|>TIETJENS JR<|>PERSON<|>Author of a study on obstructive sleep apnea in cardiovascular disease\")  \n##\n(\"entity\"<|>CLAMAN D<|>PERSON<|>Co-author of a study on obstructive sleep apnea in cardiovascular disease\")  \n##\n(\"entity\"<|>KEZIRIAN EJ<|>PERSON<|>Co-author of a study on obstructive sleep apnea in cardiovascular disease\")  \n##\n(\"entity\"<|>MARTÍNEZ-GARCÍA MA<|>PERSON<|>Author of a study on resistant hypertension\")  \n##\n(\"entity\"<|>NAVARRO-SORIANO C<|>PERSON<|>Co-author of a study on resistant hypertension\")  \n##\n(\"entity\"<|>TORRES G<|>PERSON<|>Co-author of a study on resistant hypertension\")  \n##\n(\"entity\"<|>LI N<|>PERSON<|>Author of multiple studies on hypertension and obstructive sleep apnea\")  \n##\n(\"entity\"<|>CAI X<|>PERSON<|>Co-author of multiple studies on hypertension and obstructive sleep apnea\")  \n##\n(\"entity\"<|>ZHU Q<|>PERSON<|>Co-author of multiple studies on hypertension and obstructive sleep apnea\")  \n##\n(\"entity\"<|>YAO L<|>PERSON<|>Author of a study on BMI and cardiovascular events in hypertensive patients with obstructive sleep apnea\")  \n##\n(\"entity\"<|>HEIZHATI M<|>PERSON<|>Co-author of multiple studies on hypertension and obstructive sleep apnea\")  \n##\n(\"entity\"<|>LIN M<|>PERSON<|>Co-author of a study on BMI and cardiovascular events in hypertensive patients with obstructive sleep apnea\")  \n##\n(\"entity\"<|>HU J<|>PERSON<|>Co-author of multiple studies on hypertension and obstructive sleep apnea\")  \n##\n(\"entity\"<|>WEN W<|>PERSON<|>Co-author of a study on the cardiometabolic index and cardiovascular disease\")  \n##\n(\"entity\"<|>SALMAN LA<|>PERSON<|>Author of a study on obstructive sleep apnea, hypertension, and cardiovascular risk\")  \n##\n(\"entity\"<|>SHULMAN R<|>PERSON<|>Co-author of a study on obstructive sleep apnea, hypertension, and cardiovascular risk\")  \n##\n(\"entity\"<|>COHEN JB<|>PERSON<|>Co-author of a study on obstructive sleep apnea, hypertension, and cardiovascular risk\")  \n##\n(\"entity\"<|>MANSUKHANI MP<|>PERSON<|>Author of a study on hypertension and cognitive decline in obstructive sleep apnea\")  \n##\n(\"entity\"<|>KOLLA BP<|>PERSON<|>Co-author of a study on hypertension and cognitive decline in obstructive sleep apnea\")  \n##\n(\"entity\"<|>SOMERS VK<|>PERSON<|>Co-author of a study on hypertension and cognitive decline in obstructive sleep apnea\")  \n##\n(\"entity\"<|>GAN L<|>PERSON<|>Author of studies on cortisol and aldosterone in hypertensive patients with obstructive sleep apnea\")  \n##\n(\"entity\"<|>WANG M<|>PERSON<|>Author of a study on coronary heart disease risk prediction in snorers with hypertension\")  \n##\n(\"entity\"<|>WANG MH<|>PERSON<|>Author of a study on prognostic models for high-risk patients\")  \n##\n(\"relationship\"<|>CHINESE PHYSICIANS ASSOCIATION NEPHROLOGY DIVISION<|>CHINESE SOCIETY OF INTEGRATIVE MEDICINE NEPHROLOGY COMMITTEE<|>Collaborated on the Chinese Chronic Kidney Disease Nutrition Treatment Clinical Practice Guideline<|>8\")  \n##\n(\"relationship\"<|>PRINCE M<|>TAFUR JD<|>Co-authors of a study on revascularization in atherosclerotic renal artery stenosis<|>7\")  \n##\n(\"relationship\"<|>PRINCE M<|>WHITE CJ<|>Co-authors of a study on revascularization in atherosclerotic renal artery stenosis<|>7\")  \n##\n(\"relationship\"<|>BENJAFIELD AV<|>AYAS NT<|>Co-authors of a study on the global prevalence of obstructive sleep apnea<|>7\")  \n##\n(\"relationship\"<|>BENJAFIELD AV<|>EASTWOOD PR<|>Co-authors of a study on the global prevalence of obstructive sleep apnea<|>7\")  \n##\n(\"relationship\"<|>TIETJENS JR<|>CLAMAN D<|>Co-authors of a study on obstructive sleep apnea in cardiovascular disease<|>7\")  \n##\n(\"relationship\"<|>TIETJENS JR<|>KEZIRIAN EJ<|>Co-authors of a study on obstructive sleep apnea in cardiovascular disease<|>7\")  \n##\n(\"relationship\"<|>MARTÍNEZ-GARCÍA MA<|>NAVARRO-SORIANO C<|>Co-authors of a study on resistant hypertension<|>7\")  \n##\n(\"relationship\"<|>MARTÍNEZ-GARCÍA MA<|>TORRES G<|>Co-authors of a study on resistant hypertension<|>7\")  \n##\n(\"relationship\"<|>LI N<|>CAI X<|>Co-authors of multiple studies on hypertension and obstructive sleep apnea<|>8\")  \n##\n(\"relationship\"<|>LI N<|>ZHU Q<|>Co-authors of multiple studies on hypertension and obstructive sleep apnea<|>8\")  \n##\n(\"relationship\"<|>YAO L<|>HEIZHATI M<|>Co-authors of a study on BMI and cardiovascular events in hypertensive patients with obstructive sleep apnea<|>7\")  \n##\n(\"relationship\"<|>YAO L<|>LIN M<|>Co-authors of a study on BMI and cardiovascular events in hypertensive patients with obstructive sleep apnea<|>7\")  \n##\n(\"relationship\"<|>HU J<|>CAI X<|>Co-authors of multiple studies on hypertension and obstructive sleep apnea<|>8\")  \n##\n(\"relationship\"<|>SALMAN LA<|>SHULMAN R<|>Co-authors of a study on obstructive sleep apnea, hypertension, and cardiovascular risk<|>7\")  \n##\n(\"relationship\"<|>SALMAN LA<|>COHEN JB<|>Co-authors of a study on obstructive sleep apnea, hypertension, and cardiovascular risk<|>7\")  \n##\n(\"relationship\"<|>MANSUKHANI MP<|>KOLLA BP<|>Co-authors of a study on hypertension and cognitive decline in obstructive sleep apnea<|>7\")  \n##\n(\"relationship\"<|>MANSUKHANI MP<|>SOMERS VK<|>Co-authors of a study on hypertension and cognitive decline in obstructive sleep apnea<|>7\")  \n##\n(\"relationship\"<|>GAN L<|>LI N<|>Co-authors of studies on cortisol and aldosterone in hypertensive patients with obstructive sleep apnea<|>8\")  \n##\n(\"relationship\"<|>GAN L<|>HEIZHATI M<|>Co-authors of studies on cortisol and aldosterone in hypertensive patients with obstructive sleep apnea<|>8\")  \n##\n(\"relationship\"<|>WANG M<|>WANG MH<|>Co-authors of studies on prognostic models for high-risk patients<|>7\")  \n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_10f89274df4d61869b734c160564982624fd0ce67f384f1cd0375a38c924511f_v2"}